|
 |
|
Appendix GExamples of Potential Needs and Uses for Biospecimens by Constituency
| User Type |
Needs |
Uses |
| Academic Researchers |
20-100 samples or more per experiment
< 100 mg to 100-200mg
Standard clinical quality
RNA grade
Protein grade |
Biology (genetic basis of human disease)
Aberrations of signal transduction
Genomic analysis, i.e., mutation
screening, loss-ofheterzygosity
studies, etc. |
| Pharmaceutical Companies |
20-100 samples per experiment
Multiple experiments
(~ 1,000 samples per year)
< 100 mg to 100-200 mg
Standard clinical quality
RNA grade
Protein grade |
Drug and diagnostics development
Target credentialing and validation |
| Biotechnology Companies |
20-100 samples per experiment
Multiple experiments
(~ 1,000 samples per year)
< 100 mg to 100-200 mg
Standard clinical quality
RNA grade
Protein grade |
Biomarker discovery and validation
Target identification |
|
| |
Return to Table of ContentsNext Appendix: Appendix H:
Guidance on Informed Consent for Tissue Repositories Top of Page
|
|